ABSTRACT
INTRODUCTION
and increased incidence of several autoimmune diseases such as type 1 diabetes mellitus, multiple sclerosis, systemic lupus erythematosis (2) . On the other hand, experimental data showed that administration of vitamin D prevented or suppressed some kinds of autoimmune diseases such as encephalomyelitis, arthritis, and inflammatory bowel disease (2) (3) (4) . In several studies VDR polymorphism has long been suspected to associate with thyroiditis, based on the evidence that auto reactive T cells developed in the absence of active or functional VDR; however the results were conflicting or lack of the relation between vitamin D levels (5).
Hashimoto's thyroiditis (HT) is the most common autoimmune thyroid disease with a strong genetic predisposition involved in the etiology. The anti-thyroid immune response begins with activation of thyroid antigen specific helper T cells (6) . Thyroid autoimmunity is also suspected to confer with human leukocyte antigen (HLA) class-II genes, as in animal models active vitamin D was shown to prevent autoimmune thyroiditis by down regulating the expression of HLA class II molecules on thyrocytes, inhibiting lymphocyte proliferation DOI:10.4158/EP12376.OR Endocrine Practice © 2013 AACE.
and secretion of inflammatory cytokines (7) . Regarding to the potential casual relation between vitamin D deficiency and development of autoimmune diseases, we investigated those two prevalent issues in a group of Turkish people. In this study, we evaluated the relation of serum 25OHD levels with anti-thyroid antibody levels and thyroid volume of patients with Hashimoto's thyroiditis, and compared to healthy control subjects.
METHODS

Study subjects
Total number of 540 individuals was included in this cross-sectional research. Study population was evaluated for thyroid function, thyroid autoimmunity and ultrasonographic features before enrollment. Subjects; [1] who were not euthyroid [2] who had diabetes, malignancy, chronic renal and/or hepatic failure or autoimmune diseases [3] who were on oral contraceptive, antiepileptic or anti-osteoporotic medication had been excluded. None of the subjects were taking vitamin and/or calcium supplements. Subjects enrolled consecutively into three groups. Group-1 composed of 180 euthyroid follow-up subjects who were previously diagnosed with primary hypothyroidism due to Hashimoto's thyroiditis and on stable dose of L-thyroxine at least for six months. Group-2 included age, sex and BMI matched 180 euthyroid subjects who admitted to our clinic for routine check-up and who have been found to have Hashimoto's thyroiditis according to presence of thyroid auto-immune antibodies and ultrasonographic characteristics of HT. Group-3 (control group) consisted of 180 healthy volunteers with negative anti-thyroid antibodies and normal thyroid ultrasound.
The study was performed between June and August, 2011. All subjects gave informed consent prior to study. Study was started after being approved by Diskapi YB Training & Research Hospital's local research ethics committee. had not normal TSH, fT3 and fT4 levels (in other terms who were not euthyroid) and/or who had abnormal hepatic or renal functions were not included. Subjects with Anti-TPO <35 IU/mL and anti-TG<40 U/mL were considered as "negative" for thyroid autoimmunity. The diagnosis of Hashimoto's thyroiditis was based on [1] anti-TPO and anti-TG positivity [2] reduced parenchymal echo and healthy control group was negative for these antibodies. The serum 25OHD concentration was determined by using a commercial ELISA kit (Immuno-biological laboratories, Minneapolis, USA) with normal ranges of 11.1-42.9 ng/mL. Vitamin D deficiency was described as "severe" for <10 ng/mL, "moderate" for 11-20 ng/mL, "mild" for 21-30 ng/mL serum levels of 25OHD for the summer period.
Statistical analyses
Data analysis was performed by using SPSS for Windows, version 15 
RESULTS
Each of the study groups were consisted of 180 subjects (123 females, 57 males) who were not different in terms of mean age and body mass index ( Table 1 ). The group-1 patients, who have chronic (Hashimoto's) thyroiditis and are taking L-thyroxine replacement, presented significantly lower 25OHD levels than the group-2 subjects, who have not been hypothyroid yet (11.4±5.2 ng/mL versus 13.1±5.9, p<0.001) and than the control subjects (15.4±6.8 ng/mL, p<0.001). All subjects were euthyroid as mentioned in the selection criteria.
When compared to control population, all subjects with HT (Group-1 and Group-2) had significantly lower 25OHD levels (12.2±5.6 ng/mL versus 15.4±6.8 ng/ml, p<0.001). There was a significant negative correlation between serum 25OHD levels and Anti-TPO (r= -0.361, p<0.001) and Anti-TG levels (r= -0.335, p<0.001). On the other hand, significant positive correlation was found between serum 25OHD levels and thyroid volume (r=0.145, p<0.001).
When compared between genders, the mean serum 25OHD level of all female subjects (n=369) was significantly lower than males (n=171) (11.71±5.5 ng/mL versus 16.6±6.3 ng/mL, p<0.001) ( Table 2 ). Male control subjects had the highest 25OHD levels (19.3±5.9 ng/mL) while female patients with HT and on L-thyroxine replacement (Group-1) had the lowest (10.3±4.5 ng/mL) (p<0.001). The female group-2 subjects presented the second DOI:10.4158/EP12376.OR Endocrine Practice © 2013 AACE. lowest 25OHD levels (11.4±6.4 ng/mL) and followed by control female subjects (13.5±4.9 ng/mL).
The comparison of characteristics of all study subjects according to severity of vitamin D deficiency is shown on Table- 
DISCUSSION
Vitamin D deficiency is a prevalent health problem in Turkey. Erkal et al had showed that more than 78% of Turkish people had below 25 ng/ml serum 25OHD levels independent of where they resided (9) . In another study, Ergür and colleagues revealed the frequency of severe vitamin D deficiency as 27% among women in reproductive age (10). However there is not enough data about vitamin D levels of patients with Hashimoto's thyroiditis. The higher prevalence of vitamin D deficiency in our study population can be attributable to presence of Hashimoto's thyroiditis. In our study population 94.4% of subjects had 25OHD < 25 ng/mL, while 42.8% of females presented severe deficiency. Tamer and colleagues reported lower serum vitamin D levels in HT patients (16.3±10 ng/ml) compared to healthy control subjects (29.6±25.5) in a younger population with mean age 34.8 (11) . Similarly, Kivity et al found below 10 ng/ml 25OHD levels in 79% of patients with HT (12). Distinct from these two studies, we excluded the HT patients who were not in euthyroid status because of the potential group 1 subjects who are on LT4 replacement were smaller, as expected. However, anti body positive euthyroid subjects (group 2) would have greater thyroid volumes than control group.
Although statistically non significant, this discordance may be due to sample size or to iodine deficiency of the subjects in the control group. Further placebo controlled prospective studies and laboratory analyses are needed to evaluate how vitamin D replacement therapy would influence serum anti body titers or how LT4 replacement may influence vitamin D metabolism. The urinary excretion of iodine must be kept in mind as a factor to evaluate, especially in the epidemic areas for iodine deficiency such as Turkey, while designing studies.
In conclusion, we showed that patients with Hashimoto's thyroiditis present lower 
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